JPMorgan Chase & Co’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Buy |
|
|||||
|
2025
Q1 | $2.07M | Sell |
|
|||||
|
2024
Q4 | $2.37M | Sell |
|
|||||
|
2024
Q3 | $10.7M | Buy |
|
|||||
|
2024
Q2 | $3.26M | Sell |
|
|||||
|
2024
Q1 | $4.87M | Sell |
|
|||||
|
2023
Q4 | $6.95M | Buy |
|
|||||
|
2023
Q3 | $3.22M | Buy |
|
|||||
|
2023
Q2 | $2.34M | Sell |
|
|||||
|
2023
Q1 | $3.05M | Buy |
|
|||||
|
2022
Q4 | $2.86M | Sell |
|
|||||
|
2022
Q3 | $2.35M | Sell |
|
|||||
|
2022
Q2 | $4.58M | Buy |
|
|||||
|
2022
Q1 | $2.48M | Sell |
|
|||||
|
2021
Q4 | $2.59M | Buy |
|
|||||
|
2021
Q3 | $780K | Buy |
|
|||||
|
2021
Q2 | $655K | Sell |
|
|||||
|
2021
Q1 | $1.3M | Buy |
|
|||||
|
2020
Q4 | $576K | Buy |
|
|||||
|
2020
Q3 | $539K | Buy |
|
|||||
|
2020
Q2 | $409K | Buy |
|
|||||
|
2020
Q1 | $316K | Buy |
|
|||||
|
2019
Q4 | $217K | Hold |
|
|||||
|
2019
Q3 | $121K | Buy |
|
|||||
|
2019
Q2 | $117K | Buy |
|
|||||
|
2019
Q1 | $126K | Sell |
|
|||||
|
2018
Q4 | $186K | Buy |
|
|||||
|
2018
Q3 | $135K | Buy |
|
|||||
|
2018
Q2 | $192K | Sell |
|
|||||
|
2018
Q1 | $2.21M | Buy |
|
|||||
|
2017
Q4 | $848K | Buy |
|
|||||
|
2017
Q3 | $192K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $29K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1K | Hold |
|
|||||
|
2016
Q1 | $1K | Hold |
|
|||||
|
2015
Q4 | $1K | Buy |
|